NOMAD Power Solutions, Inc. (NMAD) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$3.64

From 52W high−55.10%

Volume295159.00

Market cap$58.12M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataSep 18, 2026

Open

$3.64

From 52W high

−55.10%

Volume

295159.00

Market cap

$58.12M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−8.9x

P/E (TTM)

—

RSI (14)

43.5

MomentumView details →

1D Return

+0.00%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−8.9x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

2430.9x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

+20.75%

EBITDA YoY

—

MomentumView details →

1D Return

+0.00%

YTD Return

—

1Y Return

—

RSI (14)

43.5

vs 50D SMA

−14.99%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.05x

Current Ratio

12.87x

Quick Ratio

12.87x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.16

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−8.64M

Op. CF (TTM)

−5.35M

Latest newsMore news →

No recent news for NMAD.

Similar companies

PDS Biotechnology CorporationPDSB Heron Therapeutics, Inc.HRTX eXoZymes, Inc.EXOZ Xilio Therapeutics, Inc.XLO MiNK Therapeutics, Inc.INKT Dogwood Therapeutics, Inc.DWTX Find similar companies →

Latest newsMore news →

No recent news for NMAD.